Product NDC: | 0574-0016 |
Proprietary Name: | Clinda-Derm |
Non Proprietary Name: | Clindamycin Phosphate |
Active Ingredient(s): | 10 mg/mL & nbsp; Clindamycin Phosphate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0574-0016 |
Labeler Name: | Paddock Laboratoratories, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063329 |
Marketing Category: | ANDA |
Start Marketing Date: | 19921001 |
Package NDC: | 0574-0016-02 |
Package Description: | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0574-0016-02) > 60 mL in 1 BOTTLE, WITH APPLICATOR |
NDC Code | 0574-0016-02 |
Proprietary Name | Clinda-Derm |
Package Description | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (0574-0016-02) > 60 mL in 1 BOTTLE, WITH APPLICATOR |
Product NDC | 0574-0016 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin Phosphate |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 19921001 |
Marketing Category Name | ANDA |
Labeler Name | Paddock Laboratoratories, LLC |
Substance Name | CLINDAMYCIN PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |